New Zealand markets open in 3 hours 7 minutes

GSK plc (GSK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
42.07+0.54 (+1.29%)
As of 12:52PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close41.53
Open41.82
Bid42.08 x 2200
Ask42.09 x 800
Day's range41.64 - 42.24
52-week range33.20 - 42.61
Volume3,317,432
Avg. volume3,470,156
Market cap85.962B
Beta (5Y monthly)0.26
PE ratio (TTM)13.93
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.47 (3.50%)
Ex-dividend date22 Feb 2024
1y target estN/A
  • Yahoo Finance

    Moderna CEO: 2024 is year of growth, with 2023 transition in rearview

    Moderna posted strong results despite investors assuming a loss for the year.

  • Insider Monkey

    30 Most Valuable Drug Companies in 2024

    In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want to skip our detailed analysis of the pharmaceutical drugs market, you can go directly to 5 Most Valuable Drug Companies in 2024. The Global Pharmaceutical Drugs Market According to a report by The Business Research […]

  • Reuters

    UPDATE 1-US bill poses risk to Wuxi AppTec and its Western drugmaker partners

    A draft U.S. bill that has triggered a sell-off in shares of China's biotech firm Wuxi Apptec could deal a major blow not just to the firm but could also impact many labs and Western drugmakers that rely on it for research and manufacturing, public data showed. A congressional committee focused on China introduced a bill late last month that would restrict federally funded medical providers from allowing China's BGI Group, Wuxi Apptec and other biotech firms from getting genetic information about Americans. The bill has a long path forward before potentially becoming law.